Patrick Droesch

Clinical Science Associate (Orphan/Ultra-Rare Disease Sales) at Amgen

Role
Clinical Science Associate - Orphan Ultra-rare Sales (Amgen Acquired Horizon in October 2023) at Amgen
Location
Columbus, OH, US
LinkedIn followers
500 followers

About Patrick Droesch

I bring over 29 years of success in biotech and pharmaceutical sales, with a focus on…

Experience

  1. Clinical Science Associate - Orphan Ultra-rare Sales (Amgen Acquired Horizon in October 2023)

    Amgen

    Oct 2023 — Present

    Currently I am a Clinical Science Associate on an elite sales team (1 of 6 CSAs) in the Orphan/Ultra-Rare Disease Unit at Amgen and accountable for all sales of an ultra-rare orphan drug in 8 states and D.C. in the Mid-Atlantic Region. I have experience in all phases of the ultra-rare disease product lifecycle from launch phase to growth phase to mature 2023 Amgen Excellence in Collaboration AwardResponsible for sales of Procysbi (cysteamine bitartrate) delayed-release capsules for treatment of an ultra-orphan disease - nephropathic cystinosis (lysosomal storage disorder)- to academic institutions, children\'s hospitals, pediatric nephrologists, adult nephrologists, geneticists, and metabolic disorder specialists. Note: There are approximately 500 nephropathic cystinosis patients in the U.S. and globally making this an extremely rare-disease market and selling environment.

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Patrick Droesch — Clinical Science Associate - Orphan Ultra-rare Sales (Amgen Acquired Horizon in October 2023) at Amgen in Columbus, OH, US | Unifers